EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY-NC-ND 4.0

Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases ( PRIDD ) measure: European Delphi data

N Trialonis-Suthakharan iD, R Pattinson iD, N Tahmasebi Gandomkari iD, J Austin iD, C Janus, N Courtier iD, R M Hewitt iD, C Bundy iD, M Augustin iD

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.19266 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von N Trialonis-Suthakharan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlobalSkin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Global Research on the Impact of Dermatological Diseases (GRIDD) project is developing a patient‐reported measure of the impact of dermatological disease on the patient's life called Patient Reported Impact of Dermatological Diseases (PRIDD). We developed a list of 263 potential impact items through a global qualitative interview study with 68 patients. We next conducted a Delphi study to seek consensus on which of these items to prioritize for inclusion in PRIDD. This study aims to explore patterns in demographic (e.g. country) and clinical variables (e.g. disease group) across the impacts ranked as most important to European dermatology patients.

Methods

We conducted a modified, two rounds Delphi study, testing the outcomes from the previous qualitative interview study. Adults (≥18 years) living with a dermatological disease were recruited through the International Alliance of Dermatology Patient Organizations' (GlobalSkin) membership network. The survey consisted of a demographic questionnaire and 263 impact items and was available in six languages. Quantitative data were collected using ranking scales and analysed against a priori consensus criteria. Qualitative data were collected using free‐text responses and a Framework Analysis was conducted. European data were obtained, and descriptive statistics, including multiple subgroup analyses, were performed.

Results

Out of 1154 participants, 441 Europeans representing 46 dermatological disease from 25 countries participated. The results produced a list of the top 20 impacts reported by European patients, with psychological impacts accounting for the greatest proportion.

Conclusion

This study identified what patients consider to be the most important issues impacting their lives as a result of their dermatological disease. The data support previous evidence that patients experience profound psychological impacts and require psychological support. The findings can inform research, clinical practice and policy by indicating research questions and initiatives that are of most benefit to patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresAdultHumansConsensusSurveys and QuestionnairesDelphi Technique

Autor:innen und Institutionen

  • Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • School of Healthcare Sciences, Cardiff University, Cardiff, UK.
  • International Alliance of Dermatology Patient Organizations, Ottawa, Canada.

ORCID-Profile: N Trialonis-Suthakharan, R Pattinson, N Tahmasebi Gandomkari, J Austin, N Courtier, R M Hewitt, C Bundy, M Augustin

Förderung

  • GlobalSkin

Zitieren

APA

Trialonis-Suthakharan, N., Pattinson, R., Tahmasebi Gandomkari, N., Austin, J., Janus, C., Courtier, N., Hewitt, R. M., Bundy, C., & Augustin, M. (2023). Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases ( PRIDD ) measure: European Delphi data. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19266

Vancouver

Trialonis-Suthakharan N, Pattinson R, Tahmasebi Gandomkari N, Austin J, Janus C, Courtier N, et al. Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases ( PRIDD ) measure: European Delphi data. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.19266

BibTeX
@article{TrialonisSuthakharan2023,
  author = {Trialonis-Suthakharan, N and Pattinson, R and Tahmasebi Gandomkari, N and Austin, J and Janus, C and Courtier, N and Hewitt, R M and Bundy, C and Augustin, M},
  title = {Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases ( PRIDD ) measure: European Delphi data},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.19266}
}
Kostenlos starten →